|
BioScrip hosted a webinar to address trends, challenges, and specialty pharmacy issues in the HIV community. Please view the webinar to learn more about options payors have to better manage the HIV disease state.
The marketplace for HIV continues to evolve — including continued diversity in patient demographics, patient treatment and compliance considerations. New government efforts to warn of HIV risk and emerging pharma news, including the recent announcement by drug makers GSK and Pfizer to create a new company to invest in the research and development of HIV treatments, underscore continued interest in HIV as a growth/management segment.
Market patterns within this complicated category continue to present unique challenges for Specialty Pharmacy companies, patients, providers and payors. Leading specialty companies, including BioScrip, are approaching the management of this complicated disease category by emphasizing innovative Specialty Pharmacy solutions.
This webinar will address:
*
Trends in HIV/AIDS
*
Challenges and Opportunities
*
HIV/AIDS Specialty Solutions
|
